MyAverix Finance
CO · Healthcare
Novo Nordisk A/S (NOVO-B)
Drug Manufacturers - General
Novo Nordisk A/S (NOVO-B) is listed on CO in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-24, reported market cap is $1.28T, P/E ratio is 10.55, net margin is 37.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NOVO-B
Novo Nordisk A/S (NOVO-B) — FAQ
What is Novo Nordisk A/S's market cap?
Novo Nordisk A/S (NOVO-B) has a reported market cap of $1.28T (data as of 2026-05-24).
What is NOVO-B's P/E ratio?
The price-to-earnings (P/E) ratio for Novo Nordisk A/S (NOVO-B) is 10.55 (data as of 2026-05-24).
Does Novo Nordisk A/S pay a dividend?
Dividend yield is not available in the current snapshot for Novo Nordisk A/S (NOVO-B). Check the MyAverix Finance app for the latest dividend data.
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S (NOVO-B) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is NOVO-B listed on?
NOVO-B is listed on CO.
What is Novo Nordisk A/S's net margin?
Novo Nordisk A/S (NOVO-B) reports a net margin of 37.2% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.